Proper patient stratification based on predictive biomarkers can improve outcome in cancer immunotherapy.We describe clinical and pathologic prognostic factors that predict CD137 expression on natural killer cells after treatment with monoclonal antibodies. Our efforts constitute the first step in developing a nomogram that predicts outcome and individualizes CD137-targeted therapies for patients.
http://annonc.oxfordjournals.org/cgi/content/short/mdw570v1?rss=1
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου